CV-03
Target
Indication
Hit
Lead
Tox
Non-Clinical
Ph 1
Detail
DDR1
Renal Fibrosis
Rare Cancer
Target
Indication
Lead
DDR1
Renal Fibrosis
Rare Cancer
DDR1 inhibition-mediated anti-cancer mechanism
A first-in-class therapeutic
targeting DDR1
- A novel mechanism that can overcome the fundamental resistance to KRAS inhibitors
- Improves the tumor immune microenvironment
- Inhibits the progression of fibrotic diseases
